The delegation, led by Alisher Temirov, Director of the Center for Pharmaceutical Products Safety, Uzbekistan, had detailed discussions with Ranga Chandrashekar, Joint Drugs Controller of India ...

Neumora's lead asset, Navacaprant, shows weak efficacy in phase 2 trial. Read why we are not optimistic about NMRA's ...

Pharmaceutical companies are often lambasted for rising drug costs. For example, the price of new drugs entering the US market in 2023 was 35% higher than in 2022. According to an analysis from ...

VTDigger publishes a variety of stories on public safety, including crime, the court system, fire and EMS, law enforcement and prisons. Sign up to receive our free weekly roundup of public safety ...

Shares of Strides Pharma Science Ltd are in focus on Wednesday morning after the drugmaker said its associate company, OneSource Specialty Pharma, has received confirmed commitments for ...

Shifting”, “Trojan Horse”, Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR ...

With over 80 key companies active in the RNA therapies space, the market is projected to grow due to advancements in mRNA, siRNA, and antisense oligonucleotide-based therapies. Emerging RNA-based ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug WASHINGTON -- The Supreme Court on Monday ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and ...

BALLERUP, Denmark, October 15, 2024 -- ( BUSINESS WIRE )-- NOT FOR UK USE – NOT INTENDED FOR UK MEDIA ...

Traws Pharma Inc (TRAW) reports significant net loss but showcases promising developments in its clinical pipeline and ...

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – A/S, a clinical-stage biotech ...